{"cik":"0001650648","ticker":"FDMT","name":"4D Molecular Therapeutics, Inc.","sic_code":"2836","sic_description":"Biological Products, (No Diagnostic Substances)","exchange":"Nasdaq","state_of_incorporation":"DE","fiscal_year_end":"1231","first_filing_date":"2026-05-12","last_filing_date":"2026-07-20","url":"/sec/cik-0001650648","insider_summary":{"total_transactions":20,"unique_insiders":9,"latest_transaction":"2026-07-10"},"recent_filings":[{"accession_number":"0001193125-26-308409","form_type":"8-K","form_type_family":"current","doc_date":"2026-07-20","title":"8-K — 4D Molecular Therapeutics, Inc. — 2026-07-20","url_slug":"/sec/cik-0001650648/8-k/0001193125-26-308409","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/0001193125-26-308409-index.html"},{"accession_number":"0001834021-26-000004","form_type":"4","form_type_family":"insider","doc_date":"2026-07-14","title":"4 — 4D Molecular Therapeutics, Inc. — 2026-07-14","url_slug":"/sec/cik-0001650648/4/0001834021-26-000004","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/0001834021-26-000004-index.html"},{"accession_number":"0001958244-26-000444","form_type":"144","form_type_family":"other","doc_date":"2026-07-09","title":"144 — 4D Molecular Therapeutics, Inc. — 2026-07-09","url_slug":"/sec/cik-0001650648/144/0001958244-26-000444","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/0001958244-26-000444-index.html"},{"accession_number":"0001920738-26-000004","form_type":"4","form_type_family":"insider","doc_date":"2026-07-02","title":"4 — 4D Molecular Therapeutics, Inc. — 2026-07-02","url_slug":"/sec/cik-0001650648/4/0001920738-26-000004","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/0001920738-26-000004-index.html"},{"accession_number":"0001950047-26-006669","form_type":"144","form_type_family":"other","doc_date":"2026-06-30","title":"144 — 4D Molecular Therapeutics, Inc. — 2026-06-30","url_slug":"/sec/cik-0001650648/144/0001950047-26-006669","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/0001950047-26-006669-index.html"},{"accession_number":"0001193125-26-286880","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-29","title":"8-K — 4D Molecular Therapeutics, Inc. — 2026-06-29","url_slug":"/sec/cik-0001650648/8-k/0001193125-26-286880","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/0001193125-26-286880-index.html"},{"accession_number":"0001920738-26-000002","form_type":"4","form_type_family":"insider","doc_date":"2026-06-25","title":"4 — 4D Molecular Therapeutics, Inc. — 2026-06-25","url_slug":"/sec/cik-0001650648/4/0001920738-26-000002","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/0001920738-26-000002-index.html"},{"accession_number":"0001834021-26-000002","form_type":"4","form_type_family":"insider","doc_date":"2026-06-23","title":"4 — 4D Molecular Therapeutics, Inc. — 2026-06-23","url_slug":"/sec/cik-0001650648/4/0001834021-26-000002","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/0001834021-26-000002-index.html"},{"accession_number":"0001950047-26-006432","form_type":"144","form_type_family":"other","doc_date":"2026-06-23","title":"144 — 4D Molecular Therapeutics, Inc. — 2026-06-23","url_slug":"/sec/cik-0001650648/144/0001950047-26-006432","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/0001950047-26-006432-index.html"},{"accession_number":"0001193125-26-277563","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-22","title":"8-K — 4D Molecular Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001650648/8-k/0001193125-26-277563","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/0001193125-26-277563-index.html"},{"accession_number":"0001958244-26-000396","form_type":"144","form_type_family":"other","doc_date":"2026-06-22","title":"144 — 4D Molecular Therapeutics, Inc. — 2026-06-22","url_slug":"/sec/cik-0001650648/144/0001958244-26-000396","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/0001958244-26-000396-index.html"},{"accession_number":"0001193125-26-276163","form_type":"4","form_type_family":"insider","doc_date":"2026-06-18","title":"4 — 4D Molecular Therapeutics, Inc. — 2026-06-18","url_slug":"/sec/cik-0001650648/4/0001193125-26-276163","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/0001193125-26-276163-index.html"},{"accession_number":"0001193125-26-276160","form_type":"4","form_type_family":"insider","doc_date":"2026-06-18","title":"4 — 4D Molecular Therapeutics, Inc. — 2026-06-18","url_slug":"/sec/cik-0001650648/4/0001193125-26-276160","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/0001193125-26-276160-index.html"},{"accession_number":"0001193125-26-253740","form_type":"4","form_type_family":"insider","doc_date":"2026-06-02","title":"4 — 4D Molecular Therapeutics, Inc. — 2026-06-02","url_slug":"/sec/cik-0001650648/4/0001193125-26-253740","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/0001193125-26-253740-index.html"},{"accession_number":"0001958244-26-000339","form_type":"144","form_type_family":"other","doc_date":"2026-06-01","title":"144 — 4D Molecular Therapeutics, Inc. — 2026-06-01","url_slug":"/sec/cik-0001650648/144/0001958244-26-000339","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/0001958244-26-000339-index.html"},{"accession_number":"0000921895-26-001391","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-05-15","title":"SCHEDULE 13G/A — 4D Molecular Therapeutics, Inc. — 2026-05-15","url_slug":"/sec/cik-0001650648/schedule-13g-a/0000921895-26-001391","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/0000921895-26-001391-index.html"},{"accession_number":"9999999995-26-001626","form_type":"EFFECT","form_type_family":"other","doc_date":"2026-05-13","title":"EFFECT — 4D Molecular Therapeutics, Inc. — 2026-05-13","url_slug":"/sec/cik-0001650648/effect/9999999995-26-001626","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/9999999995-26-001626-index.html"},{"accession_number":"0000093751-26-000197","form_type":"SCHEDULE 13G","form_type_family":"other","doc_date":"2026-05-12","title":"SCHEDULE 13G — 4D Molecular Therapeutics, Inc. — 2026-05-12","url_slug":"/sec/cik-0001650648/schedule-13g/0000093751-26-000197","edgar_url":"https://www.sec.gov/Archives/edgar/data/1650648/0000093751-26-000197-index.html"}],"related_endpoints":{"profile":"/sec/FDMT/profile","timeline":"/sec/FDMT/timeline","peers":"/sec/FDMT/peers","insider_pulse":"/sec/FDMT/insider-pulse","insider_summary":"/sec/FDMT/insider-summary","insider_transactions":"/sec/FDMT/insider-transactions","form144":"/sec/FDMT/form144","holdings_as_filer":"/sec/FDMT/holdings","financial_facts":"/sec/FDMT/financial-facts","derivatives":"/sec/FDMT/derivatives","officers":"/sec/FDMT/officers","insider_network":"/sec/FDMT/insider-network","risk_flags":"/sec/FDMT/risk-flags","filings":"/sec/FDMT/filings","cross_topic_dossier":"/api/v1/dossier?ticker=FDMT"}}